AKR1B10 and hepatocellular carcinoma: Therefore, we further investigated the dynamic changes of serum concentrations of AKR1B10 by ELISA in an independent cohort of 21 HCC patients who were followed up for one week after surgical removal of primary tumors (designated as follow-up cohort; Table 1 and Fig. 6).